EP1807067A4 - Sphingosine kinase activator and skin disease treating agent comprising the same - Google Patents

Sphingosine kinase activator and skin disease treating agent comprising the same

Info

Publication number
EP1807067A4
EP1807067A4 EP05817632A EP05817632A EP1807067A4 EP 1807067 A4 EP1807067 A4 EP 1807067A4 EP 05817632 A EP05817632 A EP 05817632A EP 05817632 A EP05817632 A EP 05817632A EP 1807067 A4 EP1807067 A4 EP 1807067A4
Authority
EP
European Patent Office
Prior art keywords
same
treating agent
skin disease
sphingosine kinase
kinase activator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05817632A
Other languages
German (de)
French (fr)
Other versions
EP1807067A1 (en
Inventor
Byeong-Deog Park
Jong-Kyung Youm
Hyung-Sub Gwak
Mi-Jong Kwon
Yong-Moon Lee
Yoo-Hun Kim
Hwan-Mook Kim
Song-Kyu Park
Ki-Ho Lee
Chang-Woo Lee
Myong-Lyoll Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neopharm Co Ltd
Original Assignee
Neopharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020050096591A external-priority patent/KR100607438B1/en
Application filed by Neopharm Co Ltd filed Critical Neopharm Co Ltd
Publication of EP1807067A1 publication Critical patent/EP1807067A1/en
Publication of EP1807067A4 publication Critical patent/EP1807067A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/74—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
EP05817632A 2004-11-03 2005-10-27 Sphingosine kinase activator and skin disease treating agent comprising the same Withdrawn EP1807067A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20040088553 2004-11-03
KR1020050096591A KR100607438B1 (en) 2004-11-03 2005-10-13 Skin disease treating agent containing sphingosine kinase activator
PCT/KR2005/003586 WO2006049404A1 (en) 2004-11-03 2005-10-27 Sphingosine kinase activator and skin disease treating agent comprising the same

Publications (2)

Publication Number Publication Date
EP1807067A1 EP1807067A1 (en) 2007-07-18
EP1807067A4 true EP1807067A4 (en) 2010-08-18

Family

ID=36319380

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05817632A Withdrawn EP1807067A4 (en) 2004-11-03 2005-10-27 Sphingosine kinase activator and skin disease treating agent comprising the same

Country Status (2)

Country Link
EP (1) EP1807067A4 (en)
WO (1) WO2006049404A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008023998A1 (en) * 2006-08-22 2008-02-28 Industrial Research Limited N-acylethanolamines as wound healing agents
KR101750238B1 (en) * 2016-04-27 2017-06-27 (주)네오팜 Compositions for anti-aging
KR101828240B1 (en) * 2016-10-17 2018-02-13 (주)네오팜 Composition for anti-inflammatory
KR101828241B1 (en) * 2016-10-17 2018-02-13 (주)네오팜 Composition for anti-inflammatory
CN113861060B (en) * 2021-11-05 2023-12-08 江苏弘和药物研发有限公司 Synthesis method of sphingosine kinase agonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3334210A1 (en) * 1983-09-22 1985-04-04 Henkel KGaA, 4000 Düsseldorf Ethoxylation products of hydroxycarboxamides and their use as low-foam surfactants
KR19980034991A (en) * 1996-11-11 1998-08-05 안용찬 Non-natural ceramide-related compounds and external skin preparations containing them

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CASTIEL-HIGOUNENC I ET AL: "AUGMENTATION DU CONTENU EN CERAMIDES DES EPIDERMES HUMAINS RECONSTRUITS APRES TRAITEMENT AVEC UN SPHINGOLIPIDE EXOGENE A BASE SPHINGANINE//EXOGENOUS SPHINGANIN DERIVED SPHINGOLIPID INCREASES EPIDERMAL CERAMIDE CONTENT IN HUMAN RECONSTRUCTED SKIN", NOUVELLES DERMATOLOGIQUES, STRASBOURG, FR, vol. 18, no. 8, 1 January 1999 (1999-01-01), pages 541 - 546, XP008022965, ISSN: 0752-5370 *
See also references of WO2006049404A1 *

Also Published As

Publication number Publication date
WO2006049404A1 (en) 2006-05-11
EP1807067A1 (en) 2007-07-18

Similar Documents

Publication Publication Date Title
HK1216080A1 (en) Compositions and methods for treating or preventing oxalate-related disease
EP1814909A4 (en) Use of aimp2dx2 for the diagnosis and treatment of cancer
IL190332A0 (en) Human antibodies against il13 and therapeutic uses
IL177216A0 (en) Benzamide derivatives and their use as glucokinase activating agents
EP1871245A4 (en) Tissue dilation systems and related methods
EP1758605A4 (en) Prouroguanylin as therapeutic and diagnostic agents
IL186616A (en) Spiro-oxindole compounds and their use as therapeutic agents
PL379553A1 (en) Vanilloid receptor ligands and their use in treatments
HK1110508A1 (en) Compositions and methods of their use for improving the condition and appearance of skin
EP1874800A4 (en) Diagnostic and therapeutic agents
PL1921077T3 (en) Agent for treating and/or preventing sleep disorder
EP1891929A4 (en) Skin cosmetic and wrinkle-reducing agent
EP1781685A4 (en) Therapeutic and diagnostic agents
ZA200711105B (en) Novel physiological substance nesfatin substance relevant thereto, and use of the substances
HK1105361A1 (en) Skin conditioning agent
EP1736173A4 (en) Damaged tissue therapeutic agent and therapeutic method
ZA200705881B (en) Formulations and treatments for well-being
EP1840948A4 (en) Fine treatment agent and fine treatment method using same
EP1807067A4 (en) Sphingosine kinase activator and skin disease treating agent comprising the same
EP1944039A4 (en) Drug for treating tumor and use thereof in the manufature of medicaments for treating tumor
GB2411834B (en) Composition for use in the treatment of dry skin conditions
EP1776956A4 (en) Preventive and/or therapeutic agent for calcipenia
EP1951914A4 (en) Diagnostic and therapeutic methods and agents
IL185575A0 (en) Benzoxazocines and their therapeutic use
EP1743622A4 (en) Winkle reduction agent and cosmetic skin preparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070502

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100719

RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 19/00 20060101ALI20100713BHEP

Ipc: A61K 8/68 20060101ALI20100713BHEP

Ipc: A61K 31/164 20060101AFI20060922BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110216